{"database": "lobbying", "table": "lobbying_activities", "rows": [[1260895, "8f911f37-f8f9-4586-a0cb-15d9cc2d3782", "Q2", "THE PETRIZZO GROUP, INC.", 305932, "SAGE THERAPEUTICS, INC.", 2012, "second_quarter", "MED", "Advocated for federal funding to support development of neuroactive steroids research yielding therapeutics with a core focus on Traumatic Brain Injury (TBI), Post-Traumatic Stress Disorder (PTSD), and Pain.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2012-07-12T10:23:48.893000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1260895"], "units": {}, "query_ms": 0.40596199687570333, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}